Thanks to an increasing uptake of branded drugs in Asia-Pacific (APAC), the region’s breast cancer therapeutics market value will climb from $1.5 billion in 2013 to $2.5 billion by 2020, at a Compound Annual Growth Rate (CAGR) of 7.6%, forecasts the...
via Marketing - Latest News http://ift.tt/1qOxlgm
via Marketing - Latest News http://ift.tt/1qOxlgm
No comments:
Post a Comment